{"lastModified":"2025-06-05T22:00:32","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacja.xsp?typ=int&nr=9617","rel":"web-description"},{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DGE9LL","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/9617/body","rel":"body"}],"num":9617,"receiptDate":"2025-04-28","term":10,"title":"Interpelacja w sprawie refundacji nowoczesnych terapii dla pacjentek z zaawansowanym rakiem piersi z niską ekspresją HER2 (HER2-low)","answerDelayedDays":0,"from":["454"],"recipientDetails":[{"answerDelayedDays":0,"name":"minister zdrowia","sent":"2025-05-06"}],"replies":[{"attachments":[{"URL":"https://api.sejm.gov.pl/sejm/term10/interpellations/attachment/ATTDHCHCC/i09617-o1.pdf","lastModified":"2025-06-05T22:00:32","name":"i09617-o1.pdf"}],"from":"Podsekretarz stanu Jerzy Szafranowicz","key":"DHCHCC","lastModified":"2025-06-05T22:00:32","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DHCHCC","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/9617/reply/DHCHCC/body","rel":"body"}],"onlyAttachment":true,"prolongation":false,"receiptDate":"2025-06-04"}],"sentDate":"2025-05-06","to":["minister zdrowia"]}